A Multiple Ascending Dose Study of MEDI7247 in Patients With Selected Relapsed/Refractory Hematological Malignancies

Clinical trial NCT03106428 · COMPLETED

Trial details

NCT number: NCT03106428
Sponsor: MedImmune LLC
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Acute Myeloid Leukemia Multiple Myeloma Diffuse Large B-cell Lymphoma

Start date: 2017-03-29
Primary completion: 2020-01-03
Enrollment: 67

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.